Showing results (141-150 of 686) with videos related to
Sort By:
Pageof 69
The Journal of Clinical Investigation|May 15, 2025
Disease classification, diagnostic challenges, and evolving clinical trial design in MASLDMette Munk Lauridsen, Kim Ravnskjaer, Lise Lotte Gluud, et al.Annals of Hepatology|October 6, 2015
Drug-induced fatty liver disease: An overview of pathogenesis and managementSanjaya K Satapathy, Vanessa Kuwajima, Jeffrey Nadelson, et al.Hepatology (Baltimore, Md.)|January 6, 2015
Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint WorkshopArun J Sanyal, Scott L Friedman, Arthur J McCullough, et al.Frontiers in Endocrinology|January 11, 2021
Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic SteatohepatitisManu V Chakravarthy, Mohammad S Siddiqui, Mikael F Forsgren, et al.Nature Medicine|September 3, 2024
Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.Journal of Hepatology|April 29, 1998
Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis CM L Shiffman, C M Hofmann, V A Luketic, et al.Digestive Diseases and Sciences|November 19, 1997
An atypical presentation for primary sclerosing cholangitisV A Luketic, D A Gomez, A J Sanyal, et al.Nature Medicine|July 4, 2018
Mechanisms of NAFLD development and therapeutic strategiesScott L Friedman, Brent A Neuschwander-Tetri, Mary Rinella, et al.Hepatology (Baltimore, Md.)|December 3, 2011
Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysisJasmohan S Bajaj, Steven D Pinkerton, Arun J Sanyal, et al.Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 1998
Treatment of fulminant hepatic failure with intravenous prostaglandin E1R K Sterling, V A Luketic, A J Sanyal, et al.Pageof 69